Cindy Pynadath is a Nephrology physician affiliated with Montefiore Medical Center. OpenAlex indexes 40 publications with 1,041 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 East 210th Street
Rosenthal C, 2nd Floor
Bronx, NY 10467
Telephone
877-287-3536Provider last certified this registry record 8 Sept 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20231 payment
- Veloxis Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.5%Statin12.2%Atorvastatin Calcium60%Pravastatin Sodium24%Rosuvastatin Calcium10%Simvastatin6%Part D<11 patientsBeta blocker11.2%Carvedilol51%Metoprolol Tartrate36%Metoprolol Succinate13%Part D≥55 patients+ 10 more classes in this area
Metabolism & gastrointestinal
29.3%Corticosteroid6.1%Prednisone100%Part D≥72 patientsH2 blocker4.5%Famotidine100%Part D≥43 patients+ 9 more classes in this area
Genitourinary & hormones
7.6%alpha-Adrenergic Blocker6.9%Tamsulosin Hcl100%Part D≥66 patients5-alpha Reductase Inhibitor0.7%Finasteride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biopsy-Proven Thrombotic microangiopathy After Kidney Transplantation: Insights from a Single-Center Case Series analysis
American Journal of Transplantation
2026 - Do Preimplantation Biopsies Predict Allograft Loss and Function in Deceased-Donor Kidney Transplants?
Journal of the American Society of Nephrology
2025 - Outcomes of Kidney Grafts from Older Donors with AKI That Were Declined - A Single Center Analysis
American Journal of Transplantation
2025 - Donor Factors Predicting Allograft Loss and Function in Deceased-Donor Kidney Transplant Recipients
American Journal of Transplantation
2025 - Short-Term Kidney Graft Outcomes from Medically Complex Donors: A Single Center Analysis
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Michelle Gong, MD
Montefiore Medical Center
Sheryl Haut, MD
Montefiore Medical Center
Andreas Kaubisch, MD
Montefiore Medical Center
Lewis Eisen, MD
Montefiore Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”